A Phase I/II Trial Evaluating The Use Of a Histone Deacetylase Inhibitor Panobinostat (LBH589) In Addition To Glucocorticoids In Patients With Acute Graft-Versus-Host Disease

被引:0
|
作者
Perez, Lia
Fernandez, Hugo F.
Tomblyn, Marcie
Locke, Frederick L.
Field, Teresa
Pidala, Joseph
Elmer, Erika
Beato, Francisca
Villagra, Alejandro
Anasetti, Claudio
机构
关键词
D O I
10.1182/blood.V122.21.3308.3308
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3308
引用
收藏
页数:1
相关论文
共 50 条
  • [1] A Phase I/II Trial Evaluating the Use of a Histone Deacetylase Inhibitor Panobinostat (LBH589) in Addition to Glucocorticoids in Patients with Acute Graft-Versus-Host Disease
    Perez, Lia
    Field, Teresa
    Riches, Marcie L.
    Fernandez, Hugo F.
    Locke, Frederick L.
    Betts, Brian C.
    Pidala, Joseph
    Elmer, Erika
    Beato, Francisca
    Lienlaf, Maritza
    Horna, Pedro
    Villagra, Alejandro
    Anasetti, Claudio
    BLOOD, 2014, 124 (21)
  • [2] A Phase Trial Evaluating the Use of a Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients with Acute Graft Versus Host Disease
    Perez, Lia Elena
    Fernandez, Hugo
    Tomblyn, Marcie
    Locke, Frederick
    Field, Teresa
    Pidala, Joseph
    Elmer, Erika
    Beato, Francisca
    Anasetti, Claudio
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S337 - S338
  • [3] Phase I trial of histone deacetylase inhibitor panobinostat in addition to glucocorticoids for primary therapy of acute graft-versus-host disease
    Perez, Lia
    Fernandez, Hugo
    Horna, Pedro
    Riches, Marcie
    Locke, Frederick
    Field, Teresa
    Powers, John
    Sahakian, Eva
    Villagra, Alejandro
    Mishra, Asmita
    Betts, Brian
    Kharfan-Dabaja, Mohamed
    Beato, Francisca
    Ochoa-Bayona, Leonel
    Pidala, Joseph
    Anasetti, Claudio
    BONE MARROW TRANSPLANTATION, 2018, 53 (11) : 1434 - 1444
  • [4] Phase I trial of histone deacetylase inhibitor panobinostat in addition to glucocorticoids for primary therapy of acute graft-versus-host disease
    Lia Perez
    Hugo Fernandez
    Pedro Horna
    Marcie Riches
    Frederick Locke
    Teresa Field
    John Powers
    Eva Sahakian
    Alejandro Villagra
    Asmita Mishra
    Brian Betts
    Mohamed Kharfan-Dabaja
    Francisca Beato
    Leonel Ochoa-Bayona
    Joseph Pidala
    Claudio Anasetti
    Bone Marrow Transplantation, 2018, 53 : 1434 - 1444
  • [5] A Phase II Trial Evaluating the Use of the Histone Deacetylase Inhibitor Panobinostat for Graft-Versus-Host Disease (GVHD) Prevention
    Perez, Lia
    Fernandez, Hugo F.
    Khimani, Farhad
    Ayala, Ernesto
    Kharfan-Dabaja, Mohamed A.
    Mishra, Asmita
    Ochoa, Leonel
    Betts, Brian C.
    Pidala, Joseph
    Anasetti, Claudio
    BLOOD, 2017, 130
  • [6] A phase I trial of the histone deacetylase inhibitor panobinostat (LBH589) and epirubicin in patients with solid tumor malignancies
    Munster, P. N.
    Petrou, P.
    Ryan, C. J.
    Jahan, T. M.
    DuBois, S. G.
    Rugo, H. S.
    Chan, J. K.
    Thurn, K. T.
    Reinert, A.
    Daud, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] A phase I trial of the histone deacetylase inhibitor panobinostat (LBH589) and epirubicin in patients with solid tumor malignancies
    Moore, A. P.
    Thomas, S.
    Ryan, C. J.
    Jahan, T. M.
    DuBois, S. G.
    Chan, J. K.
    Thurn, K. T.
    Reinhert, A.
    Daud, A.
    Munster, P. N.
    EJC SUPPLEMENTS, 2010, 8 (07): : 130 - 131
  • [8] A phase I trial of the histone deacetylase inhibitor panobinostat (LBH589) and epirubicin in patients with solid tumor malignancies.
    Moore, A. P.
    Thomas, S.
    Ryan, C. J.
    Jahan, T. M.
    DuBois, S. G.
    Chan, J. K.
    Thurn, K. T.
    Collisson, E. A.
    Reinert, A.
    Daud, A.
    Munster, P. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] A phase I trial of the histone deacetylase inhibitor panobinostat (LBH589) and epirubicin in patients with solid tumor malignancies.
    Moore, Amy Patricia
    Thach-Giao Truong
    Thurn, Kenneth Ted
    Thomas, Scott
    Ryan, Charles J.
    Jahan, Thierry Marie
    DuBois, Steven G.
    Chan, John K.
    Rugo, Hope S.
    Collisson, Eric Andrew
    Raha, Paromita
    Chen, Stephanie
    Reinert, Anne
    Daud, Adil
    Munster, Pamela N.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [10] A phase 2 trial of the histone deacetylase inhibitor panobinostat for graft-versus-host disease prevention
    Perez, Lia
    Fernandez, Hugo
    Kharfan-Dabaja, Mohamed
    Khimani, Farhad
    Betts, Brian
    Mishra, Asmita
    Ayala, Ernesto
    Locke, Frederick L.
    Ochoa-Bayona, Leonel
    Nieder, Michael
    Pidala, Joseph
    Achille, Alex
    Powers, John
    Sahakian, Eva
    Thapa, Ram
    Wang, Xuefeng
    Anasetti, Claudio
    BLOOD ADVANCES, 2021, 5 (13) : 2740 - 2750